News in Brief
Computer Science - Jun 2
Satellite images, phone data guide pandemic aid in at-risk developing countries
Satellite images, phone data guide pandemic aid in at-risk developing countries
Social Sciences - Jun 2
Stanford scholars examine racism, social change and how to build a more just future
Stanford scholars examine racism, social change and how to build a more just future
Life Sciences - Jun 2
Designing animal studies to improve research reproducibility and reduce animal use
Designing animal studies to improve research reproducibility and reduce animal use
science wire
« BACK
Health - Pharmacology - 08.05.2020 
An innovation plan to beat Covid-19
For humans, the Covid-19 virus is a novel foe. And to combat a new pathogen, we need innovation: a new vaccine, new drugs, new tests, new clinical knowledge, and new data for epidemiology models.
Pharmacology - Health - 08.05.2020
Pharmacology - Health - 08.05.2020
Pharmacology - 07.05.2020 
Flowbone can help prevent bone fractures caused by osteoporosis
EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The startup they created, called Flowbone, has just made it through the second round of the Venture Kick competition. Femoral neck fractures occur frequently among the elderly, and are usually caused by osteoporosis - a disease that weakens the bone structure.
Health - Pharmacology - 07.05.2020
Pharmacology - Health - 07.05.2020 
Repurposing existing drugs for COVID-19 a more rapid alternative to a vaccine, say researchers
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology .
Health - Pharmacology - 07.05.2020
Health - Pharmacology - 07.05.2020
Pharmacology - Health - 07.05.2020
Pharmacology - Health - 06.05.2020
Health - Pharmacology - 06.05.2020
Health - Pharmacology - 06.05.2020
Health - Pharmacology - 05.05.2020
Health - Pharmacology - 05.05.2020
Health - Pharmacology - 01.05.2020
Pharmacology - Health - 01.05.2020
Health - Pharmacology - 30.04.2020
Health - Pharmacology - 29.04.2020
Health - Pharmacology - 29.04.2020
Pharmacology - Health - 29.04.2020
Pharmacology - Health - 29.04.2020
Health - Pharmacology - 29.04.2020
Pharmacology - Health - 28.04.2020 
Pandemic profiting: Vaccines and PPE on the dark web
Vendors on the dark web are selling Personal Protective Equipment (PPE) and drugs marketed as coronavirus vaccines or cures at high cost, according to a new study from The Australian National University (ANU).
Pharmacology - Economics / Business - 28.04.2020
Health - Pharmacology - 28.04.2020
Health - Pharmacology - 27.04.2020
Health - Pharmacology - 24.04.2020
Health - Pharmacology - 23.04.2020
Health - Pharmacology - 23.04.2020 
Projects funded by donor-led COVID-19 response fund
Imperial has announced the winners of the first round of funding for projects tackling the coronavirus pandemic.
Pharmacology - Health - 23.04.2020 
Possible coronavirus drug: university pharmacists produce generic medication
In response to a lack of potential coronavirus medications on the market, pharmacists from the University of Basel have begun to produce tablets themselves.
Health - Pharmacology - 23.04.2020 
Trial Launched to Test Prophylactic Treatments for COVID-19 Contact Persons
With the easing of measures, there is a pressing need for tools and approaches to contain potential new COVID-19 outbreaks.
Health - Pharmacology - 22.04.2020
Pharmacology - Health - 22.04.2020
Pharmacology - Pedagogy - 22.04.2020
Pharmacology - Health - 22.04.2020
Health - Pharmacology - 22.04.2020 
Text service to support at-risk respiratory patients during COVID-19
While many hospital services are on pause due to the COVID-19 pandemic, Sydney University researchers have established a free text service to help people with existing chronic respiratory diseases.
Pharmacology - Health - 22.04.2020
Health - Pharmacology - 22.04.2020
Health - Pharmacology - 22.04.2020 
On Earth Day, lessons from Covid-19 pandemic offer hope
"Every emergency reveals that 'impossible' things are actually doable," President Rafael Reif writes in Boston Globe op-ed.
Pharmacology - Health - 21.04.2020
Health - Pharmacology - 20.04.2020
Pharmacology - Health - 20.04.2020
Health - Pharmacology - 17.04.2020
Health - Pharmacology - 17.04.2020
Health - Pharmacology - 17.04.2020 
Coronavirus vaccine team secures funding to move towards human trials
Researchers working on a vaccine for COVID-19 have been awarded government funding to take the work forward towards human trials.
Health - Pharmacology - 17.04.2020
Health - Pharmacology - 17.04.2020
Pharmacology - Health - 17.04.2020
Health - Pharmacology - 17.04.2020
Health - Pharmacology - 16.04.2020
Pharmacology
Results 51 - 100 of 1813.
For humans, the Covid-19 virus is a novel foe. And to combat a new pathogen, we need innovation: a new vaccine, new drugs, new tests, new clinical knowledge, and new data for epidemiology models.
Operation Warp Speed targets a COVID-19 vaccine by January, but much is still unknown
FACULTY Q&A In late April, the federal government announced Operation Warp Speed, an aggressive COVID-19 vaccine development program that aims to have at least 300 million doses of vaccine available in the United States by January.
FACULTY Q&A In late April, the federal government announced Operation Warp Speed, an aggressive COVID-19 vaccine development program that aims to have at least 300 million doses of vaccine available in the United States by January.
Better antibiotic dosing could save lives in ICU
“We found a patient's response to the antibiotic improved significantly if the dosage was monitored and altered accordingly,” Dr Abdul-Aziz said.
“We found a patient's response to the antibiotic improved significantly if the dosage was monitored and altered accordingly,” Dr Abdul-Aziz said.
EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The startup they created, called Flowbone, has just made it through the second round of the Venture Kick competition. Femoral neck fractures occur frequently among the elderly, and are usually caused by osteoporosis - a disease that weakens the bone structure.
Researchers launch race to develop sustainable COVID-19 vaccine delivery
Scientists are launching a major new research project in India that will help to engineer an efficient and sustainable delivery mechanism - ready to get an eventual COVID-19 vaccine to billions of people around the globe. Researchers racing to develop, test and manufacture an effective coronavirus vaccine will also need to distribute the drug globally, but universal vaccine access is already a major challenge, particularly in low-income countries across the global South - partly due to the lack of robust cold-chains.
Scientists are launching a major new research project in India that will help to engineer an efficient and sustainable delivery mechanism - ready to get an eventual COVID-19 vaccine to billions of people around the globe. Researchers racing to develop, test and manufacture an effective coronavirus vaccine will also need to distribute the drug globally, but universal vaccine access is already a major challenge, particularly in low-income countries across the global South - partly due to the lack of robust cold-chains.
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology .
New medical foundation invests in COVID-19 research funding
Snow Medical has announced a $5.5m gift to the Universities of Sydney and Melbourne to plug coronavirus research gaps and fast-track economic recovery.
Snow Medical has announced a $5.5m gift to the Universities of Sydney and Melbourne to plug coronavirus research gaps and fast-track economic recovery.
Ethics around businesses marketing unproven and unlicensed COVID-19 stem-cell-based "therapies"
As the public looks for treatments for SARS-CoV-2, some businesses in the United States are marketing unlicensed and unproven stem-cell-based "therapies" and exosome products that claim to prevent or treat the disease.
As the public looks for treatments for SARS-CoV-2, some businesses in the United States are marketing unlicensed and unproven stem-cell-based "therapies" and exosome products that claim to prevent or treat the disease.
Scottish Universities receive funding to find COVID-19 treatments
The Universities of Glasgow and Dundee have been awarded £225,000 to rapidly screen for potential COVID-19 treatments.
The Universities of Glasgow and Dundee have been awarded £225,000 to rapidly screen for potential COVID-19 treatments.
Remdesivir, tested at Stanford Medicine, authorized for emergency use against COVID-19
Stanford Medicine researchers who participated in two separate clinical trials are encouraged by data indicating that remdesivir can treat COVID-19.
Stanford Medicine researchers who participated in two separate clinical trials are encouraged by data indicating that remdesivir can treat COVID-19.
New report models Italy’s potential exit strategy from COVID-19 lockdown
Researchers have analysed the likely impact of easing lockdown measures in Italy and the impact on transmission of coronavirus. Reducing lockdown measures in Italy could lead to a larger spike in coronavirus deaths than previously seen in some regions, their report warns. The analysis comes from the Imperial team modelling the spread and impact of COVID-19.
Researchers have analysed the likely impact of easing lockdown measures in Italy and the impact on transmission of coronavirus. Reducing lockdown measures in Italy could lead to a larger spike in coronavirus deaths than previously seen in some regions, their report warns. The analysis comes from the Imperial team modelling the spread and impact of COVID-19.
COVID-19 pandemic could significantly increase HIV, TB and malaria cases
Some regions may see deaths related to HIV, TB and malaria increase by up to 10, 20 and 36% respectively over five years due to the COVID-19 pandemic.
Some regions may see deaths related to HIV, TB and malaria increase by up to 10, 20 and 36% respectively over five years due to the COVID-19 pandemic.
Stacks in the Corner
One-of-a-kind clinic provides hope for treatment of hoarding disorder Climbing the steep gravel path to Ri Parrish's house, a serene, empty silence hovers above the stark vistas surrounding the property, dotted and perfumed by occasional pine trees.
One-of-a-kind clinic provides hope for treatment of hoarding disorder Climbing the steep gravel path to Ri Parrish's house, a serene, empty silence hovers above the stark vistas surrounding the property, dotted and perfumed by occasional pine trees.
Novartis Cosentyx gains fourth indication in EU with first-in-class approval in axial spondyloarthritis spectrum
Cosentyx is the first fully-human IL-17A inhibitor indicated for patients in Europe with non-radiographic axial spondyloarthritis (nr-axSpA), which forms part of the axial spondyloarthritis (axSpA) d
Cosentyx is the first fully-human IL-17A inhibitor indicated for patients in Europe with non-radiographic axial spondyloarthritis (nr-axSpA), which forms part of the axial spondyloarthritis (axSpA) d
UQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials
The University of Queensland 's COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.
The University of Queensland 's COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.
UofG awarded more than £1m to undertake rapid COVID-19 research
The University of Glasgow has been awarded more than £1m from the Scottish Government to undertake nine crucial COVID-19 research projects.
The University of Glasgow has been awarded more than £1m from the Scottish Government to undertake nine crucial COVID-19 research projects.
Vendors on the dark web are selling Personal Protective Equipment (PPE) and drugs marketed as coronavirus vaccines or cures at high cost, according to a new study from The Australian National University (ANU).
With iPad, COVID-19 patients see the caregiver behind the mask
Isolated COVID-19 patients benefit from interaction via iPad in Stanford Health Care's Marc and Laura Andreessen Emergency Department.
Isolated COVID-19 patients benefit from interaction via iPad in Stanford Health Care's Marc and Laura Andreessen Emergency Department.
UChicago doctors see ’remarkable’ success using ventilator alternatives for COVID-19
Editor ' s note: To read more about how UChicago is on the frontlines of the coronavirus pandemic, visit the Confronting COVID-19 website.
Editor ' s note: To read more about how UChicago is on the frontlines of the coronavirus pandemic, visit the Confronting COVID-19 website.
Imperial has announced the winners of the first round of funding for projects tackling the coronavirus pandemic.
In response to a lack of potential coronavirus medications on the market, pharmacists from the University of Basel have begun to produce tablets themselves.
With the easing of measures, there is a pressing need for tools and approaches to contain potential new COVID-19 outbreaks.
Avoiding misinformation about COVID-19 and influenza research
Misinformation with respect to science is not new, but it can be particularly troublesome and even dangerous during the COVID-19 pandemic, which has, to date, sickened millions of people around the world.
Misinformation with respect to science is not new, but it can be particularly troublesome and even dangerous during the COVID-19 pandemic, which has, to date, sickened millions of people around the world.
Imperial to begin trials of Oxford COVID-19 vaccine as London centre
Imperial College London has joined an Oxford-led clinical trial as a key site to begin testing a vaccine against COVID-19.
Imperial College London has joined an Oxford-led clinical trial as a key site to begin testing a vaccine against COVID-19.
Schoolkids search for flowers bees love most
School pupils are being asked to help scientists identify a ‘superseed' mix of wildflowers that support honeybees and other crucial pollinators.
School pupils are being asked to help scientists identify a ‘superseed' mix of wildflowers that support honeybees and other crucial pollinators.
Novartis Kymriah receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
If approved, relapsed or refractory (r/r) follicular lymphoma would become the third B-cell malignancy indication for Kymriah, joining approvals in children and young adults with r/r ALL, and adults
If approved, relapsed or refractory (r/r) follicular lymphoma would become the third B-cell malignancy indication for Kymriah, joining approvals in children and young adults with r/r ALL, and adults
While many hospital services are on pause due to the COVID-19 pandemic, Sydney University researchers have established a free text service to help people with existing chronic respiratory diseases.
Novartis announces data showing Jakavi (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease
Data from Phase III REACH2 study, published in The New England Journal of Medicine, demonstrate Jakavi can improve outcomes for patients with acute graft-versus-host disease (GvHD) who do not respond
Data from Phase III REACH2 study, published in The New England Journal of Medicine, demonstrate Jakavi can improve outcomes for patients with acute graft-versus-host disease (GvHD) who do not respond
"Every emergency reveals that 'impossible' things are actually doable," President Rafael Reif writes in Boston Globe op-ed.
Novartis announces new Mayzent (siponimod) data show sustained effect in delaying disability for up to five years in patients with secondary progressive multiple sclerosis (SPMS)
New long-term data from EXPAND show patients with SPMS continuously treated with Mayzent (siponimod) experienced lower risk of disability progression and cognitive decline than patients who delayed M
New long-term data from EXPAND show patients with SPMS continuously treated with Mayzent (siponimod) experienced lower risk of disability progression and cognitive decline than patients who delayed M
UCL, UCLH and Formula One develop life-saving breathing aids
A breathing aid developed by engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains is being deployed in NHS hospitals to help Covid-19 patients breathe more easily.
A breathing aid developed by engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains is being deployed in NHS hospitals to help Covid-19 patients breathe more easily.
’Virus Watch’ study launched to monitor spread of COVID-19 across England
Thousands of people across the country will be tested for COVID-19 as part of two new Government funded studies led by UCL and UCLH to see how the coronavirus spreads among communities and NHS workers.
Thousands of people across the country will be tested for COVID-19 as part of two new Government funded studies led by UCL and UCLH to see how the coronavirus spreads among communities and NHS workers.
Researchers working on a vaccine for COVID-19 have been awarded government funding to take the work forward towards human trials.
Pandemics of the Past and Future: A Conversation with Nobelist David Baltimore
Editor's note: This piece is part of an ongoing series on Caltech scientists who are researching the COVID-19 pandemic, each according to their own specialty.
Editor's note: This piece is part of an ongoing series on Caltech scientists who are researching the COVID-19 pandemic, each according to their own specialty.
Understanding the COVID-19 testing lag, and how we catch up
By Andrew Cohen Of the countless voices opining about the coronavirus, few have as much relevant expertise as George Horvath '14. On the medical side, he was a practicing doctor for 15 years and a partner in the Berkeley Cardiovascular Medical Group. On the legal side, he is an authority on healthcare regulation who has taught related courses at Berkeley Law as a postdoctoral fellow and lecturer since 2015.
By Andrew Cohen Of the countless voices opining about the coronavirus, few have as much relevant expertise as George Horvath '14. On the medical side, he was a practicing doctor for 15 years and a partner in the Berkeley Cardiovascular Medical Group. On the legal side, he is an authority on healthcare regulation who has taught related courses at Berkeley Law as a postdoctoral fellow and lecturer since 2015.
Leading European cancer centres share guidance on making their operations ’pandemic proof’
Seven of Europe's leading cancer centres have today published a report detailing how they have organized their healthcare systems at an unprecedented scale and pace to make their operations 'pandemic proof' during the COVID-19 pandemic.
Seven of Europe's leading cancer centres have today published a report detailing how they have organized their healthcare systems at an unprecedented scale and pace to make their operations 'pandemic proof' during the COVID-19 pandemic.
News in Brief
Computer Science - Jun 2
Satellite images, phone data guide pandemic aid in at-risk developing countries
Satellite images, phone data guide pandemic aid in at-risk developing countries
Social Sciences - Jun 2
Stanford scholars examine racism, social change and how to build a more just future
Stanford scholars examine racism, social change and how to build a more just future
Life Sciences - Jun 2
Designing animal studies to improve research reproducibility and reduce animal use
Designing animal studies to improve research reproducibility and reduce animal use